Ani Pharmaceuticals (ANIP) Tax Provisions (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Tax Provisions of $10.7 million for Q1 2026, up 171.35% sequentially from $4.0 million in Q4 2025, and up 149.51% YoY from $4.3 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Tax Provisions (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Tax Provisions for 15 years, with the latest figure at $10.7 million in Q1 2026.
- Quarterly Tax Provisions rose 149.51% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (up 467.73% YoY) and the FY2025 annual result came in at $17.5 million, up 573.01% from the prior year.
- Tax Provisions improved to $10.7 million in Q1 2026 per ANIP's latest filing, from $4.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $10.7 million in Q1 2026 and troughed at -$7.3 million in Q3 2024.
- A 5-year average of $672625.0 and a median of $246500.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions tumbled 57900.0% in 2022, then soared 914.29% in 2024.
- Over 5 years, Tax Provisions stood at -$1.5 million in 2022, then jumped by 86.06% to -$207000.0 in 2023, then plunged by 1585.99% to -$3.5 million in 2024, then jumped by 213.3% to $4.0 million in 2025, then soared by 171.35% to $10.7 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $10.7 million, $4.0 million, and $7.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 12.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 7.18 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | -3.49 Mn |
| Sep 30, 2024 | -7.30 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | -207,000.00 |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | -1.49 Mn |
| Sep 30, 2022 | -3.62 Mn |
| Jun 30, 2022 | -3.90 Mn |
| Mar 31, 2022 | -5.80 Mn |
| Dec 31, 2021 | -6.72 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -4.05 Mn |